Blood problems after Capromorelin (Entyce) in dogs
112 reports to the FDA describe blood problems in dogs given Capromorelin. That is 7.4% of all reports for this medicine, compared with 1.8% across reports for all dog medicines, so it is reported unusually often with this medicine.
112Reports
93%Marked serious
3.6%Recovered
61%Died or euthanised
14 daysTypical onset
How soon it started
How the animals did
Problems reported at the same time
Age of the animals
About this medicine
Capromorelin stimulates appetite.
Products with this ingredient include Entyce, Elura. The FDA hides brand names in its public data, so these reports cover every product with the same active ingredients.
Questions owners ask
- Can Capromorelin cause blood problems in dogs?
- 112 reports link the two, but a report alone does not prove the medicine was the cause: other illnesses, other medicines or coincidence can be involved. Your vet can judge it for your animal.
- How soon after a dose was it reported?
- In half of the reports with dates, it started within 14 days of the first dose.
- What should I do?
- Don't give another dose until you've spoken to your vet, and keep the packaging so you can tell them the product and dose. Your vet can also report it to the FDA (or you can, through the manufacturer or FDA form 1932a).
Blood problems with similar medicines
- Blood problems after Maropitant (Cerenia) 1,012 reports · 8.5% of its reports
- Blood problems after Mirtazapine (Mirataz) 45 reports · 16% of its reports
All reported side effects of Capromorelin in dogs · Medicines most reported with blood problems
